VenoStent Announces $2.3M in Seed Funding to Transform Vascular Access Surgery for Hemodialysis Patients
VenoStent Announces $2.3M in Seed Funding to Transform Vascular Access Surgery for Hemodialysis Patients Share Article Creative Ventures leads the funding round, with participation from IAG Capital Partners "While we are laser-focused on our first indication, hemodialysis access, what’s additionally so exciting is that this approach avails to us a whole host of potential applications in ‘perivascular wrapping,’" said Geoff Lucks, VenoStent’s Co-Founder and COO. NASHVILLE, Tenn. (PRWEB) February 23, 2021 VenoStent, a Houst...
Source: prweb.com